Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun;37(6):1893-7.
doi: 10.1097/CCM.0b013e31819fffd3.

Metabolic benefits of surface counter warming during therapeutic temperature modulation

Affiliations

Metabolic benefits of surface counter warming during therapeutic temperature modulation

Neeraj Badjatia et al. Crit Care Med. 2009 Jun.

Abstract

Objective: To determine the impact of counter warming (CW) with an air circulating blanket on shivering and metabolic profile during therapeutic temperature modulation (TTM).

Design: A prospective observational study.

Setting: An 18-bed neurologic intensive care unit.

Patients: Fifty mechanically ventilated patients with brain injury undergoing TTM with automated surface and intravascular devices.

Interventions: Fifty indirect calorimetry (IDC) measurements with and without CW during TTM.

Measurements and main results: IDC was continuously performed for 10-15 minutes at baseline with CW (phase I), off CW (phase II), and again after the return of CW (phase III). Shivering severity during each phase was scored on a scale of 0-3 using the Bedside Shivering Assessment Scale (BSAS). Resting energy expenditure (REE), oxygen consumption, and carbon dioxide production were determined by IDC; 56% were women, with mean age 61 +/- 15 years. At the time of IDC, 72% of patients had signs of shivering (BSAS >0). All measures of basal metabolism increased after removal of the air warming blanket (from phases I and II); REE increased by 27% and oxygen consumption by 29% (both p < 0.002). A one-point increase in baseline BSAS was noted in 55% (n = 23/42) of patients from phase I to phase II. In a multivariate analysis, sedative use (p = 0.03), baseline moderate to severe shivering (p = 0.04), and lower serum magnesium levels (p = 0.01) were associated with greater increases in REE between phase I and phase II of CW. Phase III of CW was associated with a reversal in the increases in all metabolic variables.

Conclusions: Surface CW provides beneficial control of shivering and improves the metabolic profile during TTM.

PubMed Disclaimer

Comment in

Publication types